DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Swmf Life Science Fund GP, LLC
Swmf Life Science Fund GP, LLC
corporate parent: Southwest Michigan First Corporation
Importance
3
low
Active deployment
0
low
Emerging
0
low
Completeness
56
elevated
Freshness
100
high
Research priority
1
low
Identity and regulatory footprint
- Headquarters
- Kalamazoo, MIadviserinfo.sec.gov
- Office address
- 241 EAST MICHIGAN AVENUE, Kalamazoo, MI, 49007-3909adviserinfo.sec.gov
- Business phone
- 269-553-9588adviserinfo.sec.gov
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- unknown
- Latest Form ADV
- Jul 28, 2022
- Private funds reported
- 1 (1 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $6.8Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- Southwest Michigan First Corporation (Sole Member), E
- business phone
- 269-553-9588adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
no observed deals yet
Stated (the firm’s website)
- Sectors
- healthcare, medtech, climate, edtech, logistics, industrial, agtech, media
- Stages
- not stated or not yet read
- Geography
- global, globally, michigan, midwest, north america
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
1 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Swmf Life Science Venture Fund, Limited Partnership | Fund | 2011 form d first sale | Harvest | $6.8M Jul 28, 2022 | 3 | $15.0M of $50.0M | Apr 12, 2011 |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
4 current, 3 departed
Chamber Membership
PartnerMember Exclusive Discounts
William Derlin Johnston
PartnerManager · since Jun 1, 2006
William U. Parfet
PartnerManager · since Jun 1, 2006
Kaiden Gustafson
Platform and operationsOperations
3 departed (kept with end dates)
- Douglas R. Morton · Manager · Jun 1, 2006 to Mar 31, 2015 Inference
- Goran a. Ando · Manager · Jun 1, 2006 to Mar 31, 2015 Inference
- Patrick G. Morand · Managing Director · Jun 1, 2006 to Mar 31, 2018 Inference
Investments on record
0 edges, 0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
5 dated events
- Mar 31, 2018Patrick G. Morand (Managing Director) no longer on Schedule A of Swmf Life Science Fund GP, LLC
- Mar 31, 2015Douglas R. Morton (Manager) no longer on Schedule A of Swmf Life Science Fund GP, LLC
- Mar 31, 2015Goran a. Ando (Manager) no longer on Schedule A of Swmf Life Science Fund GP, LLC
- Mar 9, 2012Swmf Life Science Fund GP, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 9, 2012Swmf Life Science Venture Fund, Limited Partnership first reported on Form ADV by Swmf Life Science Fund GP, LLC (Venture Capital Fund), GAV $46,618,116Fund first reported on Form ADVFundsFactSwmf Life Science Venture Fund, Limited PartnershipSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Corporate venture (probable, 80%, cls-1)corporate parent: Southwest Michigan First Corporation
Evidence
36 observations from 2 sources